Continental Investors Services’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,339
| Closed | -$211K | – | 65 |
|
|
2024
Q4 | $211K | Buy |
2,339
+1
| +0% | +$90 | 0.42% | 59 |
|
|
2024
Q3 | $229K | Hold |
2,338
| – | – | 0.47% | 56 |
|
|
2024
Q2 | $217K | Buy |
2,338
+3
| +0.1% | +$278 | 0.48% | 58 |
|
|
2024
Q1 | $219K | Hold |
2,335
| – | – | 0.52% | 55 |
|
|
2023
Q4 | $209K | Buy |
+2,335
| New | +$209K | 0.54% | 53 |
|
|
2023
Q3 | – | Sell |
-4,670
| Closed | -$391K | – | 64 |
|
|
2023
Q2 | $391K | Buy |
+4,670
| New | +$391K | 0.46% | 47 |
|
|
2022
Q2 | – | Sell |
-2,335
| Closed | -$261K | – | 49 |
|
|
2022
Q1 | $261K | Hold |
2,335
| – | – | 0.68% | 36 |
|
|
2021
Q4 | $210K | Buy |
+2,335
| New | +$210K | 0.56% | 47 |
|